SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-300586
Filing Date
2018-10-17
Accepted
2018-10-17 06:31:04
Documents
3
Period of Report
2018-10-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d638535d8k.htm 8-K 18820
2 EX-99.1 d638535dex991.htm EX-99.1 4669
3 GRAPHIC g638535g89m28.jpg GRAPHIC 8040
  Complete submission text file 0001193125-18-300586.txt   36235
Mailing Address 30721 RUSSELL RANCH ROAD SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30721 RUSSELL RANCH ROAD SUITE 140 WESTLAKE VILLAGE CA 91362 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35560 | Film No.: 181125384
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1